Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>-Reference-Cited by-同舟云学术

Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis

Published:2023-01-06 Issue:2 Volume:9 Page:221-238
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Jeffreys Laura N.¹^ORCID,Ardrey Alison¹,Hafiz Taghreed A.¹,Dyer Lauri-Anne¹,Warman Ashley J.¹,Mosallam Nada²,Nixon Gemma L.²^ORCID,Fisher Nicholas E.¹,Hong W. David²^ORCID,Leung Suet C.²,Aljayyoussi Ghaith¹,Bibby Jaclyn²,Almeida Deepak V.³,Converse Paul J.³,Fotouhi Nader⁴,Berry Neil G.²,Nuermberger Eric L.³,Upton Anna M.⁴⁵^ORCID,O’Neill Paul M.²^ORCID,Ward Stephen A.¹,Biagini Giancarlo A.¹

Affiliation:

1. Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K.

2. Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K.

3. Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland21205, United States

4. Global Alliance for TB Drug Development, New York, New York10005, United States

5. Evotec (US) Inc., 303B College Road East, Princeton, New Jersey08540, United States

Funder

Medical Research Council

Leverhulme Trust

National Institute for Health Research

King Saud University

Wellcome Trust

Publisher

American Chemical Society (ACS)